UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2010, ISBN 0309146283, xix, 232
Book
Vaccine, ISSN 0264-410X, 2009, Volume 28, Issue 3, pp. 589 - 590
Allergy and Immunology | Position paper | Recommendations | Vaccine | Hepatitis B | Fundamental and applied biological sciences. Psychology | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Viral hepatitis | Infectious diseases | Microbiology | Applied microbiology | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Hepatitis B Vaccines - therapeutic use | World Health Organization | Humans | Health Planning Guidelines | Hepatitis B - epidemiology | Hepatitis B Vaccines - immunology | Hepatitis B - prevention & control | Babies | Hepatitis | Immunization | Blood products | Mortality | Infections | Vaccines | Epidemiology | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2009, Volume 27, Issue 47, pp. 6550 - 6557
Allergy and Immunology | Serosurvey | Immunization | Hepatitis B | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Miscellaneous | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Viral hepatitis | Infectious diseases | Microbiology | Applied microbiology | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | Hepatitis B Core Antigens - blood | Multivariate Analysis | Age Distribution | Prevalence | Hepatitis B Vaccines - administration & dosage | Humans | Middle Aged | Child, Preschool | Hepatitis B - epidemiology | Infant | Logistic Models | Male | Seroepidemiologic Studies | China - epidemiology | Hepatitis B Surface Antigens - blood | Young Adult | Adolescent | Immunization Programs | Adult | Female | Hepatitis B - prevention & control | Child | Antigens | Infants | Epidemiology | Vaccination | Prevalence studies (Epidemiology) | Hepatitis | Vaccines | Laboratories | Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2003, Volume 63, Issue 10, pp. 1021 - 1051
Hepatitis B, prevention | Adis Drug Evaluations | Antiviral vaccines, general | Antiviral vaccines, immunogenicity | Hepatitis B vaccine recombinant, immunogenicity | Hepatitis B vaccine recombinant, general | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Immunopathology | Infectious diseases | Viral diseases | Biological and medical sciences | Immunotherapy (general aspects) | Medical sciences | Human viral diseases | Viral diseases of the digestive system | Hepatitis B - immunology | Hepatitis B Vaccines - therapeutic use | Hepatitis B Vaccines - administration & dosage | Humans | Vaccination | Immunization Schedule | Vaccines, Synthetic - therapeutic use | Hepatitis B - prevention & control | Vaccines, Synthetic - administration & dosage | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 10, pp. 914 - 922
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Viral Hepatitis Vaccines - adverse effects | Double-Blind Method | Immunoglobulin G - blood | Humans | Middle Aged | Genotype | Male | Hepatitis E virus - genetics | Young Adult | Hepatitis E - prevention & control | Viral Hepatitis Vaccines - immunology | Hepatitis E virus - immunology | Time Factors | Hepatitis Antibodies - blood | Adolescent | Hepatitis E - immunology | Adult | Female | Aged | Hepatitis E | Care and treatment | Immunization | Usage | Safety and security measures | Dosage and administration | Risk factors | Hepatitis G virus | Hepatitis | Motivation | Immunogenicity | Antibodies | Vaccines | Hepatitis B | Index Medicus | Abridged Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2008, Volume 26, Issue 49, pp. 6266 - 6273
Allergy and Immunology | Vaccination | Strategies of immunisation | Hepatitis B | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Viral hepatitis | Infectious diseases | Microbiology | Applied microbiology | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Adjuvants, Immunologic | Humans | Vaccines, DNA - immunology | Hepatitis B - epidemiology | Vaccines, DNA - therapeutic use | Mutation - genetics | Mutation - immunology | Hepatitis B - immunology | Hepatitis B Vaccines - therapeutic use | Animals | Immunization, Secondary | Hepatitis B Vaccines - adverse effects | Vaccines, DNA - adverse effects | Hepatitis B virus - genetics | Immunization Schedule | Hepatitis B Vaccines - immunology | Hepatitis B - prevention & control | Hepatitis B virus - immunology | Prevention | Mortality | Hepatitis B vaccine | Health aspects | Liver cirrhosis | Public health | Proteins | Hepatitis | Antigens | Liver diseases | Cytotoxicity | Infections | Vaccines | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 46, pp. 5300 - 5305
Allergy and Immunology | Hepatitis B vaccine | Toll-like receptor 9 agonist | Randomized trial | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Miscellaneous | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Viral hepatitis | Infectious diseases | Microbiology | Applied microbiology | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | Oligodeoxyribonucleotides - administration & dosage | Adjuvants, Immunologic - administration & dosage | Double-Blind Method | Hepatitis B Vaccines - administration & dosage | Humans | Middle Aged | Hepatitis B Surface Antigens - immunology | Male | Healthy Volunteers | Toll-Like Receptor 9 - agonists | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Hepatitis B Surface Antigens - administration & dosage | Adjuvants, Immunologic - adverse effects | Hepatitis B Antibodies - blood | Vaccination - methods | Hepatitis B Vaccines - adverse effects | Oligodeoxyribonucleotides - adverse effects | Adult | Female | Aged | Hepatitis B Vaccines - immunology | Hepatitis B - prevention & control | Adults | Safety and security measures | Hepatitis B | Health care | Hepatitis | Compliance | Licenses | Population | Infections | Vaccines | Public health | Age | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 3, pp. 304 - 305
Allergy and Immunology | Hepatitis E | Hepatitis E vaccine | Vaccination | WHO position paper | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Guidelines as Topic | Viral Hepatitis Vaccines - adverse effects | World Health Organization | Global Health | Viral Hepatitis Vaccines - administration & dosage | Humans | Middle Aged | Male | Hepatitis E - epidemiology | Young Adult | Hepatitis E - prevention & control | Viral Hepatitis Vaccines - immunology | Adolescent | Adult | Female | Medical policy | Vaccines | Medical research | Medicine, Experimental | Epidemiology | Public health | Epidemics | Immunization | Liver diseases | Transplants & implants | Displaced persons | Womens health | Mortality | Population | Infections | Index Medicus
Journal Article
Science translational medicine, ISSN 1946-6234, 11/2014, Volume 6, Issue 261, pp. 261ra153 - 261ra153
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Cell Proliferation | Hepacivirus - immunology | Viral Hepatitis Vaccines - administration & dosage | Humans | Viral Vaccines - genetics | England | Hepacivirus - genetics | Hepacivirus - pathogenicity | Healthy Volunteers | CD4-Positive T-Lymphocytes - immunology | Hepatitis C - immunology | Vaccination - methods | Time Factors | Hepatitis C Antibodies - blood | Adenoviridae - genetics | Adenoviridae - immunology | CD4-Positive T-Lymphocytes - virology | Hepatitis C - prevention & control | Interferon-gamma Release Tests | Lymphocyte Activation | Cells, Cultured | Histocompatibility Antigens Class I - immunology | Treatment Outcome | Enzyme-Linked Immunospot Assay | Pan troglodytes | Viral Vaccines - administration & dosage | Hepatitis C - diagnosis | Viral Hepatitis Vaccines - immunology | Animals | CD8-Positive T-Lymphocytes - virology | Hepatitis C - virology | Viral Hepatitis Vaccines - genetics | Immunologic Memory | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | Index Medicus | modified vaccinia Ankara | Hepatitis | Prophylactic | Adenoviral | HCV | Vaccine | Hepatitis C Virus
Journal Article